
Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2021, titled "ALKEM launches Ibuprofen and Famotidine Tablets in the United States.".
Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2021, titled "ALKEM launches Ibuprofen and Famotidine Tablets in the United States.".
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories